semaglutide effects on kidneys in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Media Centre | EASD

This method provides precise dosage control and the flexibility to adjust treatment based on the patients response

Controlled human data is more limited, which is why it remains a research-use compound in most jurisdictions the gap between animal and human evidence is its most-cited limitation

This multi-pathway approach may provide more comprehensive weight loss and metabolic health benefits

Patients with diabetic kidney disease or liver disease should use semaglutide cautiously, as the drug is cleared partly through the kidneys

This set of actions makes GLP-1 essential for keeping blood sugar levels steady and controlling hunger

When combined, these drugs create overlapping cardiovascular stress: phentermine's stimulant effect paired with semaglutide's blood-pressure-modulating properties can lead to irregular heart rhythms, elevated blood pressure episodes, and increased risk of myocardial events